News & Analysis on Clinical Trial Services & Contract Research And Development
CRO Parexel’s revenue, net income and earnings per share grew substantially in Q4 when compared to the same quarter last year and the company expects similar growth in the next fiscal year.
Albany Molecular Research's (AMRI) stock fell more than 10% on Monday after announcing in an SEC filing that it was informed by its partner Bristol-Myers Squibb that it would terminate the development of an investigational depression drug.
The licensing and potential purchase of the Taper Dry Powder Inhaler (DPI) technology from 3M complements Adamis’ portfolio and future formulation expansion, Adamis says.
The ICH last week sent its guideline on elemental impurities in drug products to the regulatory authorities in the US, EU and Japan for consultation.
Preclinical CRO Harlan has been signed up by European Commission project focused on reducing the number of animals used in research.
The US FDA has finalized guidance on clinical trial oversight, calling for more remote and targeted risk-based monitoring, though some experts believe such monitoring should be more judiciously employed.